본문 바로가기
investors

[pressrelease]legochembiosciences receives uspatent for its own proprietary adc platform technology "conjuall".

2017.04.13
legochembiosciencesreceivesuspatentforitsownproprietaryadcplatformtechnologyconjualltm.

daejeon,april13,2017

legochembioscienses(“lcb”)isabiopharmaceuticalcompanyfocusingontheresearch&developmentofadcs,basedindaejeonsouthkorea,announcedtodaythatthecompanywasawardedu.s.patentno.14517616,entitled“antibodyactiveagentconjugatesandmethodsofuse”.

thepatentillustratesthecompany’sconjualltm technology,legochem’sproprietaryadcplatformwhichenablesthedesignofhomogeneousplasmastableadcswiththepotentialforimprovedpayloaddeliverytocancercells thispatentprovideslcbcomprehensivecoverageintheunitedstatesforitsadcplatformtechnology. 

dr.yeongsoo oh,seniorvicepresident&chieftechnologyofficeroflcbsaid,“thispatentfurtherstrengthenslcb’scompetitiveadvantageinthefieldofresearchanddevelopmentofnextgenerationadcs.theuseofourtechnologywilladdress significantunmetneedsofcurrentadctechnologies.

lcbhasbeensuccessfullydevelopingglobalpartnershipsthroughthepotentialofitsproprietaryadcplatformtechnology.in2015,lcboutlicensed anantiher2adcmoleculetofosunpharmaandinjanuary2017,signedaresearchlicensingdealwithtakeda, toevaluatenextgenerationadccandidates.

 

aboutlegochembiosciences

legochembiosciencesisabiopharmaceuticalcompanyfocusingonthedevelopmentofnextgenerationnoveltherapeuticsutilizingitsproprietarymedicinaldrugdiscoverytechnologylegochemistry™&adcplatformtechnologyconjuall™.  sinceitsfoundationin2006,lcbhasfocusedontheresearchanddevelopmentofadc(antibodydrugconjugates),antibiotics,anticoagulantsandanticancertherapeuticsbasedonitsproprietaryplatformtechnologies.

aboutconjualltm

conjualltm isanextgenerationadcplatformtechnologyutilizingnovellinkerchemistrycombinedwithsitespecificenzymaticconjugation.ourplatformprovidessolutionsforsitespecificconjugation,linkerstabilityandefficientpayloadreleasewhicharethreemajorunmetneedsinadcdevelopment.

 

forlegochembiosciences

bdenquiries

jeiwookchae,chiefbusinessdevelopmentofficer

tel:+82428610688

email:bd@legochembio.com

 

media&investorsenquiries

wooshikkim,manager

tel:+827048113260

email: ir@legochembio.com